APA aipamena

Gu, C., Cheng, H., Yang, H., Bian, Y., Wang, Y., Zhang, Y., . . . Yang, Y. (2018). MK2 is a therapeutic target for high-risk multiple myeloma. Haematologica.

Chicago Style aipamena

Gu, Chunyan, Haibo Cheng, Hongbao Yang, Yong Bian, Yaohui Wang, Yifen Zhang, Michael Pisano, Gang Hu, and Ye Yang. "MK2 Is a Therapeutic Target for High-risk Multiple Myeloma." Haematologica 2018.

MLA aipamena

Gu, Chunyan, et al. "MK2 Is a Therapeutic Target for High-risk Multiple Myeloma." Haematologica 2018.